Maxime Dely: The Lifesaving Power of Plasma Donations
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
”Plasma matters more than we think.
With this 3rd donation of the year, the goal of 10 donations in 2026 remains well on track.
Beyond the gesture itself, each donation helps collect valuable components used every day in medicine.
Among them, fibrinogen plays a central role: this protein is directly involved in blood clotting, transforming into fibrin, which is essential for forming the clot that helps stop bleeding.
Without sufficient fibrinogen, certain medical procedures become far more complex, especially in cases of surgery, trauma, or specific coagulation disorders.
Donating plasma means contributing directly to an essential care chain — often invisible, yet vital for many patients.
A simple, regular, and meaningful contribution.”
Stay updated with Hemostasis Today.
-
Jun 27, 2026, 18:19Nabil Tabish: The Paradox of Zero – Investigating Extreme VWF Discordance
-
Jun 27, 2026, 18:19Francesco Favruzzo: Can Mechanical Thrombectomy Be Safely Used in Cervical Artery Dissection?
-
Jun 27, 2026, 18:18Vera Ghali: 2026 ASH–ISTH Recommendations on Pediatric VTE Prevention
-
Jun 27, 2026, 18:17Michiel Coppens: A Hemostasis Laboratory – One of the Cornerstones of Our Hemophilia Mission
-
Jun 27, 2026, 18:16Sthanu Subramanian: Dabigatran and Mechanical Heart Valves
-
Jun 27, 2026, 15:50Muhammet Özbilen: The Skin as an Emerging Regulator of Iron Homeostasis
-
Jun 27, 2026, 15:07Anteneh Berhane: Supporting Healthier Pregnancies Through Early Nutrition
-
Jun 27, 2026, 14:35Mobina Nakhaei: Why Alloantibodies Develop Despite ABO/Rh Matching in Thalassemia
-
Jun 27, 2026, 14:01Abdul Mannan: DOACs in Cancer-Associated VTE – When to Avoid Them, And When LMWH Wins